Filling the need for trusted information on national health issues…

Trending on kff Medicare & Medicaid at 50 Individual Market Medicaid Expansion

Clinical Research/R&D

  • your selections
Clear Search

Filter Results

date

Tags

  • results
Circulating Petition Asks Journal Science To Be More Sensitive To Gender, Cultural Issues

Washington Post: Hundreds of scientists ask Science to stop publishing a smorgasbord of stereotypes “More than 300 scientists and counting have signed an open letter to the journal Science, according to scientific publishing watchdog Retraction Watch. The letter, which has been circulated among scientists on social media sites such as…

IAS 2015 Set To Open In Vancouver, As Sub-Saharan Africa AIDS Conference Ends In Zimbabwe

Canadian Press/Chronicle Journal: Vancouver HIV-AIDS meeting seen as step towards goal of ending pandemic by 2030 “More than 6,000 international experts on HIV-AIDS will gather in Vancouver this weekend to share the latest scientific advances in the fight to eradicate the disease, which first emerged almost 35 years ago and…

2 Clinical Trials Of Experimental Ebola Vaccines Begin In Europe, Africa

Reuters: Two new trials of Ebola vaccines begin in Europe and Africa “Two new Ebola vaccine trials began on Wednesday with volunteers in Britain, France, and Senegal getting ‘prime-boost’ immunizations developed by Bavarian Nordic, GlaxoSmithKline, and Johnson & Johnson…” (Kelland, 7/15).

Reuters Examines Challenges Of Bringing First Malaria Vaccine To Market

Reuters: Caveats, costs, and complexities shadow first malaria vaccine “…Backed by billionaire philanthropist Bill Gates and developed by GlaxoSmithKline, the vaccine — called RTS,S or Mosquirix — is being assessed by regulators and global health authorities. Granting it a license and recommending it for rollout in sub-Saharan Africa, where malaria…

HIV Vaccine Research Helps Promote Innovation In Other Prevention Methods

Devex: Bold goal of stopping HIV is motivating great science Paul Stoffels, chief scientific officer and worldwide chair for pharmaceuticals at Johnson & Johnson “…The good news is that this massive challenge [of finding an HIV vaccine] has unleashed stunning creativity in laboratories all over the world. The bold goal…

Lancet Health Policy Paper Examines Donor Support For Various Global Health Functions

The Lancet: How much donor financing for health is channeled to global versus country-specific aid functions? Dean Jamison, a global health economist at UCSF; Lawrence Summers, a former U.S. Treasury secretary now at Harvard University; and researchers at SEEK Development in Berlin and the Karolinska Institutet in Stockholm, write, “The…